Nel ASA's Revenue Conundrum Tests Investor Patience Ahead of Q1 Report

Nel ASA's Q1 2026 results are critical as its huge order backlog hasn't turned into revenue, with analysts slashing targets ahead of the report.

With its share price languishing near 52-week lows at €0.20, Norwegian hydrogen specialist Nel ASA faces a pivotal moment. The company will release its first-quarter 2026 financial results on April 22 at 07:00 CET, followed by a virtual presentation an hour later. The event is mandatory viewing for investors seeking clarity on a persistent and costly gap: a burgeoning order book that has yet to translate into meaningful revenue.

Market skepticism is palpable. In the run-up to the report, several major investment banks have slashed their price targets. Morgan Stanley cut its target drastically from NOK 3.50 to NOK 2.00, while Citi reduced its fair value estimate to NOK 2.40. Both firms maintain a "Hold" rating, reflecting a consensus view that advises underweighting the stock. Analysts point to the stark disconnect in Nel's financials as the core issue. Its PEM division alone has amassed a backlog worth NOK 686 million, a staggering 364 percent increase. Yet this stands in stark contrast to a massive annual loss of NOK 1.27 billion.

The company's market capitalization of approximately NOK 3.86 billion, spread across over 1.8 billion outstanding shares, underscores the modest valuation afforded by wary investors. The current average analyst price target sits at NOK 2.30.

Investor focus for the upcoming report is sharply defined. Key areas include the status of the order backlog and tangible progress in ramping up electrolyzer production for heavy industry and transport. Nel's long-promised path to profitability remains unproven, and the Q1 figures must demonstrate operational improvement. Further clouding the outlook is a review of the book values for two idled production lines at the Herøya facility, which threatens to trigger additional write-downs.

A recent shareholder meeting on April 10 introduced a significant structural change, replacing the old stock option program with a new Performance Share Unit (PSU) plan. Nearly 15 million PSUs have been issued to executives and insiders, tying their compensation to specific performance targets and a long-term vesting schedule. Management frames the shift as a move to better align leadership interests with those of shareholders.

Financially, Nel enters this critical period with a solid liquidity cushion of roughly NOK 1.6 billion. The broader hope for a turnaround is pinned on the commercial launch of its new pressurized alkaline electrolyzer platform, slated for the first half of 2026. The company claims the system could slash manufacturing costs by up to 60 percent, a project bolstered by EUR 135 million in funding from the European Union.

The technical picture for the stock is weak, with a Relative Strength Index (RSI) of 34.8 indicating oversold conditions. While shares have gained about five percent over the past week, they are trading precisely at the 200-day moving average and remain just above the March low. The upcoming quarterly report must provide concrete evidence of revenue acceleration. Without a clear signal that orders are converting into sales, the stock lacks the catalyst needed for a sustained recovery. The next major milestone for investors will be the half-year report on July 15, 2026.